Rakuten Securities
RVMD icon

Rakuten Securities’s Revolution Medicines RVMD Stock Holding History

Rakuten Securities’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.2K Sell
235
-115
-33% -$22.8K 0.01% 286
2026
Q2 		$65.5K Buy
+350
New +$51.1K 0.02% 250
2025
Q4 		– Sell
-200
Closed -$9.34K – 964
2025
Q3 		$9.34K Hold
200
– – ﹤0.01% 417
2025
Q2 		$7.36K Hold
200
– – ﹤0.01% 452
2025
Q1 		$7.07K Buy
+200
New +$8.12K ﹤0.01% 447

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Rakuten Securities's RVMD Position: Q3 2026 in Review

Rakuten Securities reduced its Revolution Medicines (RVMD) stake by 33% in Q3 2026, selling an estimated $22.8K and leaving 235 shares worth $48.2K. The position accounts for 0.01% of the portfolio, ranked #286.

Rakuten Securities first reported a position in RVMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $65.5K in Q2 2026. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Rakuten Securities held 235 shares of Revolution Medicines worth $48.2K as of Q3 2026.
  • Rakuten Securities sold 115 Revolution Medicines shares in Q3 2026, an estimated $22.8K.
  • Revolution Medicines made up 0.01% of Rakuten Securities's portfolio in Q3 2026, its #286 holding.
  • Rakuten Securities first reported a position in Revolution Medicines in Q1 2025 and has held it in 5 quarters since.
  • Rakuten Securities's Revolution Medicines position peaked at $65.5K in Q2 2026.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.